Guaiphenesin Market
Guaiphenesin Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Guaiphenesin Market Size and Growth
The Guaifenesin market is poised for growth, driven by rising demand in cold and cough medications. Current market size is estimated at approximately $600 million, with a projected CAGR of 6% over the next five years. Increased awareness of respiratory health and rising self-medication trends are key market drivers. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ EMS Pharmaceutical
◍ Elan
◍ Sovereign Pharma
◍ Mission Pharma
◍ RB Pharma
◍ Orbis Biosciences
◍ Synthokem Labs
◍ Kowa
◍ Lipocine Inc
◍ Granules
◍ Iwaki Seiyaku
◍ Silarx Pharmaceuticals
◍ Haizhou Pharma
◍ Aurohealth LLC
◍ Pan Drugs
◍ Gennex Lab
◍ Prasco
The Guaiphenesin market features companies like EMS Pharmaceutical, RB Pharma, and Granules, developing formulations for cough and cold therapies. These firms contribute through innovative product development and strategic partnerships. Revenue highlights include:
- Granules: $80 million (2022)
- Mylan (Meda Pharmaceuticals): $32 billion (2022) Their efforts drive market growth and accessibility.
Request Sample Report
◍ Meda Pharmaceuticals (Mylan)
Market Segmentation
By Application
◍ Chronic Bronchitis With Phlegm
◍ Bronchiectasis
◍ Infection
◍ Other
By Product
◍ Active Pharmaceutical Ingredients ◍ Preparation
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
